QAdvis Collaboration with Swedish Medtech Continues in 2023
QAdvis will remain as a Swedish Medtech networking partner in 2023 and together we are offering ...
Voting Complete – extension of MDR transition times and removal of sell-off period for devices from MDR and IVDR
The EU Parliament has adopted the MDR amendment proposal, February 16th, and removed the sell-off ...
The 7th EAAR Annual Conference on the New Medical Device Regulations
Welcome 2-3 February in Brussels, Belgium to listen to Robert Ginsberg, Nils-Åke Lindberg and many ...
This Christmas we save children’s lives
We at QAdvis wish all of our customers and partners a Merry Christmas and a Happy New Year! This ...
QAdvis News #4 – 2022
Eighteen months have passed since the application date of the medical device regulation in May ...
Proposed changes of MDR transition times
EU Commission is proposing elements of a bridging measure for MDD certificates that expire pending ...
Life Science barometer 2022
SwedenBIO’s Life Science Barometer highlights industry trends, as well as critical needs within the ...
EU Medical Device Regulation for combination products
Do you work with at the crossroads of medtech and pharma developing combination products? Are you a ...
United to accelerate innovation in clinical research
Sweden and the Netherlands, represented by Scandinavian CRO (SCRO) and Cardialysis, are uniting in ...